Chief Executive Officer
CurrentStart-up biotech company developing small molecules to treat neuropsychiatric disorders by enhancing neuroplasticity and reducing neuro-inflammation
Mar 2021 - Present
AeroLeads people directory · profile
Pablo Lapuerta Email & Phone Number
Chief Executive Officer at 4M Therapeutics Inc.
at
4M Therapeutics Inc.
1 work email found
@4mtx.net
8 phones found area 650, 310, 908, 609, and 281
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer at 4M Therapeutics Inc.
Location
Princeton, New Jersey, United States
Company size
Who is Pablo Lapuerta? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Pablo Lapuerta is listed as Chief Executive Officer at 4M Therapeutics Inc. at 4M Therapeutics Inc., a company with 5 employees, based in Princeton, New Jersey, United States. AeroLeads shows a work email signal at 4mtx.net, phone signal with area code 650, 310, 908, 609, 281, and a matched LinkedIn profile for Pablo Lapuerta.
Pablo Lapuerta previously worked as Chief Executive Officer at 4M Therapeutics Inc. and President at Lapuerta Consulting, Llc. Pablo Lapuerta holds Md from Harvard Medical School.
Company email context
Email format at 4M Therapeutics Inc.
This section adds company-level context without repeating Pablo Lapuerta's masked contact details.
{first}@4mtx.net
89% confidence
AeroLeads found 1 current-domain work email signal for Pablo Lapuerta. Compare company email patterns before reaching out.
Profile bio
About Pablo Lapuerta
Pharmaceutical executive with broad scientific and management experience in building and leading large teams, achieving key milestones in drug development, and supporting sales, marketing, pricing, and reimbursement. Clinical experience in several areas including cardiology, endocrinology, gastroenterology, and neuroscience.Specialties: Clinical trials, medical affairs, health economics, epidemiology, and health services research.
Listed skills include Clinical Development, Clinical Trials, Drug Development, Medical Affairs, and 39 others.
Current workplace
Pablo Lapuerta's current company
Company context helps verify the profile and gives searchers a useful next step.
4M Therapeutics Inc.
13 roles · 33 years
Pablo Lapuerta work experience
A career timeline built from the work history available for this profile.
President
Current
Lapuerta Consulting, Llc
Assisting biotech clients with assets ranging from pre-clinical development to life cycle management, in areas including neurology, oncology, endocrinology, and immunology
Oct 2020 - Present
Endless Frontier Lab Graduate
he EFL is a 9 month performance-driven program that aims to translate breakthrough science into successful business through mentorship, venture capital, and business development. As an EFL graduate, I worked with senior executives across various biotechnology companies, and more to scale the success of 4M Therapeutics.
Sep 2023 - May 2024
Executive Vice President And Chief Medical Officer
Established capabilities for late stage pharmaceutical development, introducing new processes and systems, hiring new talent in clinical operations, regulatory affairs, program management, medical monitoring, biostatistics, medical affairs, and drug safety. Designed and executed successful phase 3 pivotal trial in oncology for telotristat etiprate, a new.
Mar 2013 - Sep 2020
Senior Vice President And Chief Medical Officer
Responsible for clinical development at Lexicon Pharmaceuticals: completed phase 2 studies in oncology, type 2 diabetes, ulcerative colitis, and irritable bowel syndrome. Provided oversight of phase 1 studies in clinical pharmacology and translational medicine. Additional areas of clinical development included immunology and ophthalmology.
2011 - Mar 2013
Vice President, Full Development Lead, Gamma Secretase Inhibitor
- Responsible for all development activities for a new drug intended to treat Alzheimer’s disease.
- Led a broad, multidisciplinary team of over 30 people planning and executing worldwide development (preclinical, manufacturing, clinical, regulatory) and commercialization efforts.
- Developed collaborations with diagnostic companies to support innovative use of biomarkers in Alzheimer’s Disease
- Developed global registration strategy supported by interactions with regulatory authorities. Obtained positive EMA opinion for use of novel biomarkers to identify pre-dementia Alzheimer’s Disease
- Oversaw planning and execution of phase 1 and phase 2 studies, including the first randomized trial in pre-dementia Alzheimer’s Disease
2009 - 2010
~1 yr
Senior Vice President, Clinical Strategy And Chief Medical Officer
Cogentus Pharmaceuticals
- Responsible for all clinical, medical, and regulatory activities for CGT-2168, a novel formulated combination of clopidogrel and omeprazole:
- Completed phase 1 study on pharmacokinetics and platelet aggregation with CGT-2168
- Led successful end of phase II interactions with Cardiorenal division at FDA
- Phase III international outcomes study (COGENT) was published in the New England Journal of Medicine.
- CGT-2168 significantly reduced gastrointestinal bleeding in patients with cardiovascular disease
Jul 2007 - Jan 2009
Executive Director, Global Medical Affairs
As development champion for irbesartan and irbesartan/HCTZ, held global responsibilities for all clinical and medical affairs activities. Also led medical affairs activities for all Bristol-Myers Squibb compounds in diabetes and obesity.
Feb 2006 - Jul 2007
Executive Director, Global Epidemiology And Outcomes Research
Led team conducting research in health economics, epidemiology, and health services research for all development products.
Oct 2004 - Feb 2006
Group Director
Held assignments in both US and Europe leading Outcomes Research teams.
Jun 2000 - Oct 2004
Director, Outcomes Research
Led Health Economics and Outcomes Research programs for cardiovascular, metabolic, and immunology products.
Feb 1998 - Jun 2000
Jun 1996 - Feb 1998
Assistant Professor
Conducted health services research, taught residents and medical students, and provided patient care.
1993 - 1996
~3 yrs
4 education records
Pablo Lapuerta education
Md
Harvard Medical School
Ba, Biology
Harvard University
Education record
School Year Abroad
High School Diploma
Keystone School
FAQ
Frequently asked questions about Pablo Lapuerta
Quick answers generated from the profile data available on this page.
What company does Pablo Lapuerta work for?
Pablo Lapuerta works for 4M Therapeutics Inc..
What is Pablo Lapuerta's role at 4M Therapeutics Inc.?
Pablo Lapuerta is listed as Chief Executive Officer at 4M Therapeutics Inc. at 4M Therapeutics Inc..
What is Pablo Lapuerta's email address?
AeroLeads has found 1 work email signal at @4mtx.net for Pablo Lapuerta at 4M Therapeutics Inc..
What is Pablo Lapuerta's phone number?
AeroLeads has found 8 phone signal(s) with area code 650, 310, 908, 609, 281 for Pablo Lapuerta at 4M Therapeutics Inc..
Where is Pablo Lapuerta based?
Pablo Lapuerta is based in Princeton, New Jersey, United States while working with 4M Therapeutics Inc..
What companies has Pablo Lapuerta worked for?
Pablo Lapuerta has worked for 4M Therapeutics Inc., Lapuerta Consulting, Llc, Lexicon Pharmaceuticals, Bristol-Myers Squibb, and Cogentus Pharmaceuticals.
How can I contact Pablo Lapuerta?
You can use AeroLeads to view verified contact signals for Pablo Lapuerta at 4M Therapeutics Inc., including work email, phone, and LinkedIn data when available.
What schools did Pablo Lapuerta attend?
Pablo Lapuerta holds Md from Harvard Medical School.
What skills is Pablo Lapuerta known for?
Pablo Lapuerta is listed with skills including Clinical Development, Clinical Trials, Drug Development, Medical Affairs, Pharmaceutical Industry, Clinical Research, Regulatory Affairs, and Health Economics.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial